90 Ten

What 90 Ten does

90TEN is a London-headquartered, independent healthcare communications consultancy founded in 2001, operating with approximately 70 staff across offices in London and Washington DC. The firm serves pharmaceutical, biotechnology, consumer health, and public health clients, with a stated client base covering over half of the top 20 global pharmaceutical companies. Services are delivered on a project and retainer basis through three integrated sub-brands: 90TEN Communications (public relations), 90TEN Medical (medical communications and education, staffed by academic scientists), and 20SENSES (health advocacy and patient engagement).

The firm's differentiating technical asset is the proprietary Feel-Think-Do™ methodology, an evidence-based behavioral science suite of tools co-developed with behavioral psychologists to map the emotional, cognitive, and environmental drivers behind communications challenges. This methodology is applied across all client engagements to design campaigns intended to drive measurable behavior change, with documented outcomes such as the My Journey HIV campaign co-created with the HIV community. Delivery is supported by a channel partnership with Baird's CMC, which extends effective reach to communications specialists in over 50 countries.

Since April 2020, 90TEN has operated as a wholly-owned subsidiary of Envision Pharma Group, a global evidence-based communications and technology provider backed by Ardian and GHO Capital. The parent group has approximately 800 employees across 14 offices and four continents, giving 90TEN access to the iEnvision technology platform, strategic publications planning, and broader medical communications capabilities. 90TEN retains its own brand, leadership (CEO Carole North, Chairman and co-founder Paul Tanner), and Feel-Think-Do™ methodology. Pricing is quote-based and varies by project scope, with no publicly disclosed revenue. The firm holds no patents and no AI/ML capabilities are documented; its competitive moat rests on methodology, talent retention, and enterprise pharma client relationships, validated by repeated industry awards between 2016 and 2020.

Name

90 Ten

Legal name

90TEN Group Limited

Website

https://90ten.co.uk

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

90TEN is an independent London-based healthcare communications consultancy serving pharmaceutical, biotech, and public health clients through three divisions (PR, medical communications, and health advocacy) using a proprietary Feel-Think-Do™ behavioral science methodology, with a stated client base covering over half of the top 20 global pharma companies.

Ownership category

akta.pro rank

Product category

Healthcare communications consultancy

NAICS

Advertising, Public Relations, and Related Services (5418), Public Relations Agencies (541820), Other Scientific and Technical Consulting Services (54169), Health Care and Social Assistance (62)

SIC

Services-Advertising Agencies (7311), Services-Health Services (8000)

akta.pro primary industry

Healthcare & Life Sciences PR (MPAAADAD)

akta.pro secondary industries

Healthcare & Life Sciences PR (BPAFADAJ), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Healthcare communications consultancy
• Medical communications services
• Pharmaceutical public relations
• Patient advocacy campaigns
• Behavioral science communications

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Healthcare Communications Consultancy Services: 90TEN generates revenue through providing PR, medical communications, and patient advocacy services to pharmaceutical, biotech, consumer health, and public health clients. Services are delivered on a project and retainer basis, serving enterprise healthcare companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

90TEN is a global healthcare communications consultancy providing public relations, medical communications, medical education, and patient advocacy services to pharmaceutical, biotech, consumer health, and public health organizations. The firm operates through three specialist divisions (90TEN Communications, 90TEN Medical, 20SENSES) unified by its proprietary Feel-Think-Do™ behavioral science methodology. Services are delivered on a project and retainer basis to enterprise healthcare clients, with over half of the top 20 global pharma companies as clients.

Product overview

90TEN is a global healthcare communications consultancy operating as a unified group with three specialist divisions: 90TEN Communications (public relations), 90TEN Medical (medical communications and education), and 20SENSES (health advocacy consultancy). These divisions are unified by the proprietary Feel-Think-Do™ behavioral science methodology, which underpins all service offerings to maximize brand and health outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• 90TEN Medical: Medical communications and education consultancy staffed by academic scientists and healthcare marketing experts, providing medical and scientific strategy development and communication of medical milestones
• 90TEN Communications
• 20SENSES

Products and services

• 90TEN Communications Public relations consultancy division of 90TEN providing communications services to the healthcare sector, focusing on pharmaceuticals, biotech, consumer health, and public health, using behavioral science methodologies to drive meaningful change.
• 90TEN Medical Medical communications and education consultancy division of 90TEN, staffed by academic scientists and healthcare marketing experts, offering medical and scientific strategy development and the coordination and communication of medical milestones for healthcare clients.
• 20SENSES Health advocacy consultancy division of 90TEN specializing in patient engagement, public health, and medical education, using a co-creation approach with patients and healthcare professionals to build advocacy and grassroots support for health campaigns.
• Feel-Think-Do™ behavioral science methodology Proprietary evidence-based suite of behavioral science tools developed by 90TEN with behavioral psychologists, designed to understand human emotions, thought processes, and environmental factors behind communications challenges and deliver tailored, targeted communications that inspire meaningful and positive behavior change.

Quantifiable outcome

• Nearly a third of gay men living with HIV took steps to improve their future health through the My Journey campaign co-created with the HIV community

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core and minor.

• Envision Pharma GroupcoreStrategic or Co-development Partner · 8 April 202090TEN was acquired by Envision Pharma Group, a global provider of evidence-based communication services and industry-leading technology solutions. The acquisition brings 90TEN's behavioral science, creativity, and insight-driven communications expertise to Envision's broader portfolio. 90TEN retains its brand and service offering while gaining access to Envision's global infrastructure including technology platform iEnvision, strategic publications planning, medical strategy, and expanded geographic reach.
• Baird's CMC NetworkminorChannel Partner/ Reseller/ Distributor90TEN collaborates with Baird's CMC network of agencies, which provides direct access to communications specialists in over 50 countries and across all continents of the globe. This partnership extends 90TEN's global reach for serving multinational healthcare clients.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Ogilvy Health: Healthcare communications arm of WPP/Ogilvy offering PR, medical education, and brand communications globally. Competes for the same top-20 pharma clients but as part of a much larger, broader portfolio; 90TEN's prior hire Rick Evans came from this firm.
• MSL Group (Publicis Health): Global public relations and integrated communications network with a strong healthcare practice. Directly competes for pharma communications and patient advocacy briefs as part of the Publicis Health portfolio.
• Edelman (Health practice): Global communications firm with a dedicated health practice providing PR, medical communications, and policy work to top pharma clients. Comparable offering as part of a broader portfolio but with materially larger scale.

Direct peers

• Syneos Health Communications: Communications arm of Syneos Health offering medical communications, PR, and patient engagement for pharma/biotech. Comparable in customer base, offering breadth, and integration with broader pharma services.
• Havas Life (formerly Havas Health & You): Global healthcare communications network providing medical communications, PR, and patient engagement services to pharma and biotech clients. Direct competitor for top-20 pharma accounts with comparable behavioral science and creative capabilities.
• Real Chemistry: Healthcare and life sciences communications and data-driven marketing agency serving top pharma clients across PR, medical communications, and patient engagement. Comparable in scale, customer profile, and integrated offering.
• GCI Health: Specialist healthcare public relations and communications agency serving pharma, biotech, and consumer health clients globally. Closely comparable to 90TEN in offering, target customers (top-20 pharma), and behavioral/creative campaign-led positioning.
• WE Communications: Global communications agency with a deep health practice serving pharma, biotech, and consumer health clients across PR, medical education, and patient advocacy. Comparable in offering mix, customer profile, and behavioral-science-led campaign work.
• Inizio Evoke (formerly Huntsworth Health): Global healthcare communications and advisory group serving pharma, biotech, and consumer health. One of the closest direct peers to 90TEN in offering mix, customer profile, and European HQ base.

Regional players

• Aurora Healthcare Communications: UK-based healthcare communications consultancy providing PR, medical education, and patient engagement to pharma clients. Comparable in service mix and target customers but primarily focused on the UK/European market versus 90TEN's transatlantic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/90ten
• LinkedInlinkedin.com/company/90ten-healthcare
• Facebookfacebook.com/157717221256185

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 90 Ten